GLP-1 Drugs Linked to 46% Lower Aortic Aneurysm Rupture Risk in 412,000-Patient Study
A Journal of Vascular Surgery study reports 46% lower five-year aneurysm rupture risk among GLP-1 users, a signal with implications for peptide therapy demand and supply.